Press release
Postoperative Acute Pain Market Trends, Treatments, and Global Forecast
Postoperative Acute Pain
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70919
With advances in non-opioid drugs, regional anesthesia, nerve block technologies, and digital monitoring tools, the POAP market is poised for rapid transformation. By 2034, the Postoperative Acute Pain Market is projected to reach USD 24.8 billion, up from USD 12.2 billion in 2024, growing at a CAGR of 7.2%.
Market Overview
• Market Size 2024: USD 12.2 billion
• Forecast 2034: USD 24.8 billion
• CAGR (2024-2034): ~7.2%
Key Growth Drivers:
• Rising global surgical volumes (orthopedic, cardiac, gastrointestinal, and oncology surgeries).
• Increasing awareness of patient-centric pain management.
• Shift toward opioid-sparing regimens using multimodal approaches.
• Innovation in extended-release local anesthetics and non-opioid analgesics.
Challenges:
• Continued reliance on opioids in many regions.
• Limited access to advanced pain management in developing economies.
• Regulatory complexities for novel analgesic approvals.
Leading Players:
Pfizer, Novartis AG, Eli Lilly, Teva Pharmaceuticals, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Pacira BioSciences, Grunenthal GmbH, Endo International, and AcelRx Pharmaceuticals.
Segmentation Analysis
By Product
• Opioids
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Acetaminophen
• Combination Analgesics
• Local Anesthetics & Nerve Blocks
• Novel Non-Opioid Drugs
By Platform
• Oral Drugs
• Injectable Therapies
• Transdermal Patches
• Inhalation-Based Systems
By Technology
• Extended-Release Formulations
• Regional Anesthesia Techniques
• Non-Opioid Receptor Modulators
• Digital Pain Monitoring & AI-Enabled Tools
By End Use
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Pain Clinics
• Retail & Online Pharmacies
By Application
• Orthopedic Surgeries
• General & Abdominal Surgeries
• Cardiovascular Surgeries
• Oncology-Related Surgeries
• Others (Plastic & Reconstructive Surgeries)
Segmentation Summary:
Opioids remain widely prescribed, but NSAIDs, local anesthetics, and extended-release formulations are gaining traction as safer alternatives.
Explore Full Report here: https://exactitudeconsultancy.com/reports/70919/postoperative-acute-pain-market
Regional Analysis
North America
• Largest market share (~44%).
• High surgical volumes and advanced hospital infrastructure.
• Policy reforms driving reduction in opioid prescriptions.
• Pacira's Exparel (liposomal bupivacaine) gaining adoption as a non-opioid option.
Europe
• Rising adoption of multimodal pain management protocols.
• Strong focus on regional anesthesia and non-opioid drug R&D.
• Germany, UK, and France dominate revenues.
Asia-Pacific
• Fastest-growing region (CAGR ~9%).
• Increasing surgical demand due to aging population and trauma cases.
• Expanding healthcare infrastructure in India, China, and Japan.
Middle East & Africa
• Growing surgical care facilities but limited access to novel analgesics.
• Rising investments in hospital expansion fueling demand.
Latin America
• Increasing surgical procedures in Brazil and Mexico.
• Higher adoption of generic pain management drugs.
Regional Summary:
North America and Europe lead in innovation, while Asia-Pacific shows the strongest growth potential.
Market Dynamics
Growth Drivers
• Increasing global surgical volumes.
• Strong push for opioid-sparing strategies.
• Advances in extended-release anesthetics and nerve block therapies.
• Digital health adoption for pain monitoring.
Key Challenges
• Over-prescription of opioids in certain markets.
• High costs of novel pain therapies.
• Limited awareness in developing economies.
Latest Trends
• Growing demand for liposomal drug delivery systems.
• Development of peripheral nerve block catheters for post-surgical pain.
• Adoption of AI-driven patient pain monitoring systems.
• Increasing clinical trials for non-opioid analgesics.
Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=70919
Competitor Analysis
Major Players:
1. Pfizer Inc.
2. Novartis AG
3. Eli Lilly and Company
4. Teva Pharmaceuticals
5. Johnson & Johnson
6. Pacira BioSciences
7. Endo International
8. Mallinckrodt Pharmaceuticals
9. Grünenthal GmbH
10. AcelRx Pharmaceuticals
Competitive Summary:
The POAP market is dominated by global leaders such as Pfizer, Novartis, and Eli Lilly, while Pacira BioSciences has carved out a strong niche with its non-opioid anesthetic Exparel. Generic manufacturers like Teva and Mallinckrodt strengthen the NSAID and opioid segment, while emerging players focus on digital solutions and novel non-opioid formulations.
Conclusion
The Postoperative Acute Pain Market is undergoing a major transformation, shifting from opioid-centric treatment to multimodal and non-opioid approaches. The integration of digital health technologies, extended-release local anesthetics, and personalized treatment protocols is setting new benchmarks in patient recovery.
Key Takeaways:
• Market to grow from USD 12.2 billion in 2024 to USD 24.8 billion by 2034, CAGR 7.2%.
• Multimodal pain management is becoming the new standard of care.
• North America leads in adoption, while Asia-Pacific grows fastest.
• Pharma companies are investing heavily in opioid-sparing therapies and innovative drug delivery systems.
By 2034, postoperative pain management will rely increasingly on safe, effective, and technology-driven solutions, improving recovery outcomes and reducing opioid dependency worldwide.
This report is also available in the following languages : Japanese (術後急性疼痛市場), Korean (수술 후 급성 통증 시장), Chinese (术后急性疼痛市场), French (Marché de la douleur aiguë postopératoire), German (Markt für postoperative akute Schmerzen), and Italian (Mercato del dolore acuto postoperatorio), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/70919/postoperative-acute-pain-market#request-a-sample
Our More Reports:
Antiphospholipid Syndrome Market
https://exactitudeconsultancy.com/reports/71298/antiphospholipid-syndrome-market
Arteriovenous fistula Market
https://exactitudeconsultancy.com/reports/71299/arteriovenous-fistula-market
Beta-thalassemia Market
https://exactitudeconsultancy.com/reports/71300/beta-thalassemia-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Postoperative Acute Pain Market Trends, Treatments, and Global Forecast here
News-ID: 4147931 • Views: …
More Releases from Exactitude Consultancy
Human Papillomavirus (HPV)-Associated Diseases Market Outlook 2025-2034
Introduction
Human Papillomavirus (HPV) is one of the most common viral infections worldwide and is linked to a wide range of associated diseases, including cervical cancer, oropharyngeal cancer, anal cancer, and genital warts. While most HPV infections are self-limiting, persistent high-risk strains can cause life-threatening malignancies, making HPV a significant global public health challenge.
Over the past decade, increasing vaccination coverage, improved screening programs, and advances in targeted therapies have transformed the…
Substance (Drug) Abuse Market Massive Growth opportunity Ahead
Introduction
Substance abuse-whether involving alcohol, opioids, prescription medications, or illicit drugs-remains a critical global public health issue. The socioeconomic burden is immense, affecting not only individuals but also families, communities, and healthcare systems. Rising addiction rates, mental health challenges, and increasing availability of synthetic drugs have created an urgent need for effective prevention, treatment, and rehabilitation services.
The market is expanding as governments strengthen policies, healthcare providers adopt integrated mental health and…
Thymidine Kinase 2 Deficiency (TK2d) Market New Product Development & Latest Tre …
Introduction
Thymidine Kinase 2 Deficiency (TK2d) is an ultra-rare genetic mitochondrial disorder characterized by progressive muscle weakness, respiratory failure, and severe disability, often beginning in childhood. Current treatment is limited, but advances in gene therapy, nucleoside supplementation, and mitochondrial-targeted therapies are rapidly shaping the future of this market. With increased investment in rare disease R&D, the TK2d market is emerging as a critical segment within the rare neuromuscular disease landscape.
Download Full…
Lymphatic Malformations Market Emerging Trends and Growth Prospects 2034
Introduction
Lymphatic malformations (LMs) are rare, benign vascular anomalies that occur due to abnormal development of the lymphatic system. They are most often diagnosed in children and can range from superficial cutaneous lesions to deep, extensive malformations. The treatment landscape is advancing with innovations in sclerotherapy, targeted biologics, and minimally invasive surgery, alongside growing awareness of rare diseases.
Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/71066
Market Overview
• Market Size (2024): USD…
More Releases for Pain
Enhanced Pain Relief Solutions at Advanced Pain Care
Image: https://www.globalnewslines.com/uploads/2025/03/3f3b6259bfdec02e5dcb7b9d0c838855.jpg
Advanced Pain Care is helping people who suffer from chronic pain with sophisticated, evidence-based treatments. The clinic is particularly focused on non-surgical care that improves the quality of life. With a team of highly qualified pain experts, they work with patients who have back pain, joint pain, and nerve pain.
Personalized Treatment for Every Pain Disorder
Advanced Pain Care offers treatments depending on the cause of pain. Anyone experiencing arthritis, migraine,…
Pain Finisher | Advanced Pain Relief Device
Pain Finisher is an instant pain relief device that is effective on all pains including back pain and knee pain. It is based on the TENS theory of pain management which is easy to use and safe.
By using Pain Finisher, a modern drug-free and non-invasive pain-relieving treatment method, one can get rid of the common pain creams, gels, and risky treatment methods.
So, have a pain-free life with easy-to-use pain relief…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
Visceral Pain Market Analysis 2024: Addressing Pain Management Challenges
The Business Research Company has released its latest global market reports, covering insights for 2024 and offering projections up to 2033.
The Business Research Company presents an extensive market research report on the Visceral Pain Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments.
Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities,…
Global Post-Operative Pain Management Market: Pain Relief Goes Worldwide
Introduction:
The Global Post-Operative Pain Management Market is growing at a rapid pace. This market involves the management of pain after surgical procedures. The market has witnessed significant growth in recent years, owing to the increasing number of surgeries and the rising prevalence of chronic diseases. Pain management is an essential aspect of healthcare, as uncontrolled pain can lead to prolonged hospital stays, delayed recovery, and poor patient outcomes.
In this article,…
Post-Operative Pain Management Market By Type, By Application(Cancer Pain, Arthr …
Global Post-Operative Pain Management Market- Description
Post-operative pain management is predominantly referred to as the use of a wide array of therapies or drugs to reduce muscle and tissue spasm in patients who have recently undergone a surgical procedure. It is evident that all type of surgeries, be it major or minor cause postoperative pain in patients which in turn increases their hospital stays while burdening them with psychological and physical…
